Despite the negative news and worrying headlines, we recommend traders to make mental reframing of the situation. This way, you can look at the market from a different perspective. Let’s observe how you can take advantage of the uncertainties and make the fundamentals work for you!
Johnson & Johnson ahead of earnings on April 20
Information is not investment advice
What will happen?
Johnson & Johnson, a huge pharmaceutical company, will announce its earnings results for the first quarter on April 20 at 15:30 MT. Let’s get ready!
How to trade on earnings?
It’s really easy! Just compare the forecasted earnings with the actual and follow the rule below.
- If the results are better than expected, J&J will increase its value.
- Otherwise, if earnings are worse than the forecasts, J&J will fall.
The good news for FBS traders is that they can make both buy and sell trades while trading stocks –the rules are almost the same as for the currency pairs. So, you don’t need to already have an asset to sell it.
How has J&J been doing?
Not so good! As you may know, Johnson & Johnson has produced its coronavirus vaccine. However, the rollout didn’t go well. Firstly, it has been reported recently that 4 people (out of 5.4 million) who used this vaccine got blood clots. Thus, European regulators have already started investigating the side effects. Secondly, three US vaccination sites temporarily stopped administering J&J's vaccine this week. Finally, the factory's workers occasionally mixed up some vaccine elements last month and ruined 15 million doses. Thus, 62 million of the company's vaccine doses must be checked. It will slow down the supply.
However, if all these things are fixed, Johnson & Johnson could even become the best-selling COVID-19 vaccine. Yes, yes! It has two significant advantages:
1) it can be stored with standard refrigeration and
2) it can be given in one dose!
Apart from vaccine
Johnson & Johnson is not just about the Covid-19 vaccine, it’s way more! It has a huge stable of drugs, some of them are frontrunners in their segments. Besides, the company has an amazing reputation: five consecutive years of annual revenue growth, an above-average dividend that has been increased for almost 60 years in a row!
Moreover, Johnson & Johnson is a value stock. Therefore, it can benefit from the current market rotation from growth to value stocks.
Let’s look at the chart!
On the 4-hour chart, J&J has formed a symmetrical triangle pattern. Thus, the breakout above the upper trend line at $165.00 will drive the pair further up to March high of $167.00. However, first of all, it should cross the 50-period moving average which lies just above its current price of $162.00.
On the flip side, the move below the lower trend line at $160.00 will press the pair down to the 200-period moving average of $158.50.
The stock trading is available in our app FBS Trader!
Don't know how to trade stocks? Here are some simple steps.
The US Federal Reserve may refrain from more aggressive interest rate hikes in March due to geopolitical risks after Russia's special operation in Ukraine…
Hello from the far 2022! FBS analysts have used some magic to travel to the future and brought you some hilarious predictions.
Great Britain released retail sales data on May 20, 9:00 GMT+3. The reading outperformed expectations greatly (+1.4% actual vs. -0.3% forecast).
The stock market has reversed, and now it’s going lower and lower…
Walmart is one of the biggest retail corporations in the US, with $244 billion in total assets. Does it worth buying amid rising prices and supply concerns that shatter the world economy?